- Home
- WYY vs ENZ Comparison
WYY vs ENZ Comparison
Compare WYY & ENZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WYY
- ENZ
- Stock Information
- Founded
- WYY 1991
- ENZ 1976
- Country
- WYY United States
- ENZ United States
- Employees
- WYY N/A
- ENZ N/A
- Industry
- WYY EDP Services
- ENZ Medical Specialities
- Sector
- WYY Technology
- ENZ Health Care
- Exchange
- WYY Nasdaq
- ENZ Nasdaq
- Market Cap
- WYY 37.8M
- ENZ 34.2M
- IPO Year
- WYY 1998
- ENZ N/A
- Fundamental
- Price
- WYY $3.77
- ENZ $0.58
- Analyst Decision
- WYY Strong Buy
- ENZ
- Analyst Count
- WYY 1
- ENZ 0
- Target Price
- WYY $7.00
- ENZ N/A
- AVG Volume (30 Days)
- WYY 47.3K
- ENZ 113.0K
- Earning Date
- WYY 03-25-2025
- ENZ 03-12-2025
- Dividend Yield
- WYY N/A
- ENZ N/A
- EPS Growth
- WYY N/A
- ENZ N/A
- EPS
- WYY N/A
- ENZ N/A
- Revenue
- WYY $133,124,648.00
- ENZ $30,314,000.00
- Revenue This Year
- WYY $28.46
- ENZ N/A
- Revenue Next Year
- WYY $12.97
- ENZ N/A
- P/E Ratio
- WYY N/A
- ENZ N/A
- Revenue Growth
- WYY 31.67
- ENZ N/A
- 52 Week Low
- WYY $1.83
- ENZ $0.57
- 52 Week High
- WYY $6.25
- ENZ $1.40
- Technical
- Relative Strength Index (RSI)
- WYY 41.16
- ENZ 29.86
- Support Level
- WYY $3.50
- ENZ $0.58
- Resistance Level
- WYY $3.94
- ENZ $0.69
- Average True Range (ATR)
- WYY 0.23
- ENZ 0.04
- MACD
- WYY 0.02
- ENZ 0.00
- Stochastic Oscillator
- WYY 41.89
- ENZ 7.07
About WYY WidePoint Corporation
WidePoint Corp is a provider of Technology Management as a Service (TMaaS) that consists of federally certified communications management, identity management, interactive bill presentment and analytics, and Information Technology as a Service solution. Its solutions include Telecom Lifecycle Management, Digital billing communications solutions, and Mobile and Identity management. Geographically the company generates a majority of its revenue from the United States and rest from Europe.
About ENZ Enzo Biochem Inc. ($0.01 Par Value)
Enzo Biochem Inc is a bioscience company. The firm manufactures, develops and sell their proprietary solutions and platforms to clinical laboratories, specialty clinics and researchers and physicians internationally. The company has one reportable segment, Products, which focuses on labeling and detection technologies from DNA to whole cell analysis, including a comprehensive portfolio of thousands of high-quality products, including antibodies, genomic probes, assays, biochemicals, and proteins.